Aileens Pharma is a clinical stage Italian biotech start-up founded in 2018 that is developing topical non-pharmacological and non-steroidal treatments for dermatological diseases such as atopic dermatitis.
The product acts on the altered skin microbiota of patients suffering of derma inflammatory diseases to re-equilibrate the skin homeostasis and physiology thus improving the patient’s clinical condition and quality of life.
As of today, there is no accepted and efficacious solution for pediatric patients and Aileens Pharma is poised to address that need.
The product is CE marked.
Sonia Longo Sormani
Panakès board member